Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 1304
interventional 1146
Observational 142
Registry 16

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 592
Biological 109
Biological|Drug 79
Drug|Other 51
Biological|Drug|Other 47
Drug|Procedure 29
Biological|Drug|Procedure|Radiation 22
Biological|Drug|Other|Procedure|Radiation 17
Drug|Radiation 17
Drug|Procedure|Radiation 16
Biological|Other 13
Drug|Other|Procedure|Radiation 13
Drug|placebo 12
Other 12
Procedure 12
Behavioral 11
Biological|Drug|Other|Procedure 8
Biological|Drug|Radiation 7
Drug|Genetic 7
Dietary Supplement 6
Drug|Other|Radiation 6
Biological|Drug|Procedure 5
Combination Product 5
Device 5
Drug|Genetic|Other 3
Drug|Other|Procedure 3
Biological|Device|Drug 2
Biological|Drug|Genetic|Other|Procedure 2
Biological|Procedure 2
Device|Other 2
Dietary Supplement|Other 2
Dietary Supplement|placebo 2
Other|Procedure 2
Behavioral|Drug|Other|Procedure 1
Biological|Device 1
Biological|Device|Drug|Other|Procedure 1
Biological|Device|Drug|Procedure|Radiation 1
Biological|Device|Drug|Radiation 1
Biological|Drug|Genetic|Other 1
Biological|Drug|Other|Radiation 1
Biological|Genetic|Other 1
Biological|Genetic|Other|Procedure 1
Biological|Other|Procedure 1
Biological|placebo 1
Device|Drug 1
Device|Drug|Other 1
Device|Drug|Other|Procedure|Radiation 1
Device|Drug|Procedure 1
Device|Drug|Procedure|Radiation 1
Diagnostic Test|Drug 1
Diagnostic Test|Drug|Genetic|Procedure|Radiation 1
Dietary Supplement|Drug 1
Dietary Supplement|Drug|Other 1
Drug|Genetic|Procedure|Radiation 1
Drug|Other|placebo|Procedure 1
Drug|placebo|Procedure 1
Genetic 1
Genetic|Other 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 628
China 52
Germany 36
France 26
Italy 23
Spain 21
NA 20
Japan 18
United States|Canada 17
United Kingdom 16
Canada 11
Korea, Republic of 10
United States|Australia|Canada 8
Austria 7
United States|Australia 7
Denmark 5
Mexico 5
Sweden 4
United States|Australia|Canada|Puerto Rico 4
United States|Germany|Italy 4
United States|Italy 4
Austria|Germany 3
Denmark|Finland|Iceland|Norway|Sweden 3
Israel 3
Russian Federation 3
Turkey 3
United States|Australia|Canada|Netherlands|Puerto Rico|Switzerland 3
United States|Australia|Canada|New Zealand|Puerto Rico 3
United States|Australia|Canada|New Zealand|Switzerland 3
United States|France|Germany|Italy|United Kingdom 3
United States|Germany 3
United States|United Kingdom 3
Austria|France|Germany 2
Germany|Austria 2
Hong Kong 2
Lithuania 2
Spain|United States|Argentina|Australia|Austria|Brazil|Bulgaria|Canada|Croatia|Czechia|Denmark|Egypt|Estonia|France|Germany|Hong Kong|Italy|Mexico|Netherlands|New Zealand|Romania|Russian Federation|Slovakia|Switzerland|Thailand|United Kingdom 2
Switzerland 2
United States|Australia|Austria|Belgium|France|Germany|Hungary|Italy|New Zealand|Spain|United Kingdom 2
United States|Australia|Belgium|Canada|China|Czechia|Ireland|Israel|Italy|New Zealand|Poland|Russian Federation|Spain|Turkey|Ukraine|United Kingdom 2
United States|Australia|Canada|Ireland|New Zealand|Puerto Rico|Switzerland 2
United States|Australia|Canada|New Zealand 2
United States|Australia|France|Poland 2
United States|Canada|France|Netherlands 2
United States|Canada|Puerto Rico 2
United States|Denmark|Germany 2
United States|France|Germany 2
United States|Puerto Rico|South Africa 2
Argentina|Australia|Austria|Belarus|Belgium|Canada|Chile|Croatia|Czechia|Denmark|Finland|France|Germany|Greece|Hungary|Israel|Italy|Malaysia|Mexico|Netherlands|New Zealand|Norway|Poland|Romania|Saudi Arabia|Slovakia|Slovenia|Spain|Sweden|Switzerland|Turkey 1
Argentina|Australia|Brazil|Canada|Chile|Croatia|Czechia|France|Germany|Greece|Italy|Mexico|New Zealand|Poland|Portugal|Russian Federation|Slovakia|Spain|Turkey 1
Argentina|Australia|Bulgaria|Hong Kong|Hungary|Mexico|New Zealand|Poland|Russian Federation|Taiwan 1
Argentina|Austria|Belgium|Chile|Czech Republic|Germany|Hungary|Italy 1
Argentina|Belgium|Bosnia and Herzegovina|Brazil|Canada|Egypt|Estonia|Finland|France|Germany|Greece|Ireland|Israel|Italy|Korea, Republic of|Latvia|Lithuania|Mexico|North Macedonia|Poland|Portugal|Romania|Russian Federation|Serbia|Slovakia|Slovenia|Spain|Sweden|Switzerland|Thailand|Turkey 1
Argentina|Belgium|Canada|Denmark|Finland|France|Italy|Netherlands|Norway|Sweden 1
Argentina|Croatia|Greece|Ireland|Italy|New Zealand|Russian Federation|United Kingdom 1
Argentina|Venezuela 1
Armenia|Belarus|Kyrgyzstan|Russian Federation|Uzbekistan 1
Australia|Austria|Belgium|Czech Republic|Denmark|France|Germany|Israel|Italy|New Zealand|Spain 1
Australia|Austria|Czechia|Germany|Israel|Italy|Slovakia|Switzerland 1
Australia|Austria|Czechia|Germany|Israel|Italy|Switzerland 1
Australia|Belgium|France|Germany|Italy|Korea, Republic of|Netherlands|Singapore|Spain|Sweden|United Kingdom 1
Australia|China|New Zealand|Taiwan 1
Australia|France|Germany|Hungary|Korea, Republic of|Poland|Singapore|United Kingdom 1
Australia|United Kingdom 1
Austria|Belgium|Bulgaria|Czechia|France|Germany|Hungary|Ireland|Israel|Italy|Poland|Russian Federation|Singapore|Slovakia|Sweden|Ukraine|United Kingdom 1
Austria|Belgium|Canada|France|Germany|Italy|Japan|Norway|Spain 1
Austria|Belgium|France|Germany|Italy|Netherlands|Poland|Romania|Russian Federation|Spain|United Kingdom 1
Austria|Belgium|France|Italy 1
Austria|Brazil|United States|Argentina|Australia|Bulgaria|Canada|Croatia|Czechia|Denmark|Egypt|Estonia|France|Germany|Hong Kong|Italy|Mexico|Netherlands|New Zealand|Romania|Russian Federation|Slovakia|Spain|Switzerland|Thailand|United Kingdom 1
Austria|Czechia|Slovakia 1
Austria|Finland|Germany|Russian Federation 1
Austria|France|Germany|Italy|Netherlands|United Kingdom 1
Austria|Germany|Switzerland 1
Bangladesh 1
Belarus|Poland 1
Belarus|Russian Federation|Uzbekistan 1
Belgium 1
Belgium|Brazil|United States|Australia|Canada|Czechia|Hungary|Korea, Republic of|Mexico|New Zealand|Poland|Puerto Rico|Russian Federation 1
Belgium|Croatia|Czech Republic|France|Germany|Italy|Netherlands|Portugal|Slovakia|Turkey 1
Belgium|Denmark|Estonia|Finland|Germany|Iceland|Ireland|Lithuania|Netherlands|Norway|Portugal|Sweden|United Kingdom 1
Belgium|Denmark|Netherlands 1
Belgium|France 1
Belgium|France|Germany 1
Belgium|France|Germany|Italy 1
Belgium|France|United States|Israel|Spain|United Kingdom 1
Belgium|Netherlands 1
Brazil 1
Bulgaria|Georgia|Poland 1
Canada|France 1
Canada|Germany 1
Canada|Russian Federation|Spain 1
Canada|United States|Australia|New Zealand|Switzerland 1
China|Malaysia|Australia|Taiwan 1
China|Philippines|Taiwan|Thailand|Vietnam 1
Czech Republic 1
Czechia|Denmark|France|Germany|Hungary|Israel|Italy|United States|Argentina|Australia|Austria|Brazil|Bulgaria|Canada|Korea, Republic of|Netherlands|Poland|Russian Federation|Saudi Arabia|Slovakia|South Africa|Spain|Sweden|Taiwan|Turkey|United Kingdom 1
Denmark|Estonia|Finland|Lithuania|Norway|Sweden 1
Denmark|Sweden 1
Egypt 1
France|Germany|Spain 1
France|United Kingdom 1
Germany|Austria|Belgium|Denmark|Finland|Ireland|Israel|Netherlands|Sweden|Switzerland 1
Germany|Netherlands 1
Germany|Netherlands|United Kingdom 1
Germany|United States|Australia|Austria|Belgium|Canada|Denmark|Finland|France|Hong Kong|Italy|Korea, Republic of|Netherlands|New Zealand|Norway|Poland|Singapore|Spain|Sweden|Switzerland|Taiwan|United Kingdom 1
Greece 1
Hong Kong|Japan|Malaysia|Singapore|Taiwan 1
India 1
Iran, Islamic Republic of 1
Japan|Korea, Republic of 1
Malaysia 1
Netherlands 1
Netherlands|United Kingdom 1
Poland|Spain 1
Poland|United Kingdom 1
Spain|Finland|France|Portugal|Sweden|Tunisia|Turkey|United Kingdom 1
Spain|United States|Australia|Austria|Belgium|Canada|Colombia|Czechia|Denmark|France|Germany|Hungary|Ireland|Israel|Italy|Mexico|Netherlands|New Zealand|Poland|Portugal|Romania|Russian Federation|South Africa|Sweden|United Kingdom 1
Spain|United States|Australia|Belgium|Denmark|France|Germany|Hungary|Israel|Italy|Netherlands|New Zealand|Poland|Turkey|United Kingdom 1
United States|Argentina|Australia|Austria|Belarus|Brazil|Bulgaria|Canada|Finland|France|Greece|Italy|Korea, Republic of|Poland|Russian Federation|Spain|Taiwan|Turkey 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Denmark|Finland|France|Germany|Israel|Italy|Korea, Republic of|Netherlands|Norway|Peru|Sweden|Switzerland|United Kingdom 1
United States|Argentina|Australia|Austria|Brazil|Bulgaria|Canada|Croatia|Denmark|Estonia|France|Germany|Italy|Mexico|New Zealand|Poland|Romania|Russian Federation|Spain|Switzerland|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|China|Colombia|Czechia|France|Germany|Greece|Hungary|Ireland|Israel|Italy|Korea, Republic of|Mexico|Netherlands|Poland|Portugal|Russian Federation|Spain|Sweden|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Brazil|Canada 1
United States|Argentina|Australia|Canada|China|Czechia|Finland|France|Germany|Hungary|Italy|Japan|Korea, Republic of|Netherlands|Poland|Singapore|Spain|Sweden|Taiwan|United Kingdom 1
United States|Argentina|Belgium|Brazil|Canada|Colombia|Czechia|France|Germany|Greece|Israel|Korea, Republic of|Mexico|Poland|Portugal|Russian Federation|Spain|Sweden|Turkey|Ukraine|United Kingdom 1
United States|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|Colombia|Croatia|Czechia|Denmark|France|Hungary|Israel|Italy|Netherlands|New Zealand|Poland|Portugal|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|United Kingdom 1
United States|Australia|Austria|Belgium|Bulgaria|Canada|Croatia|Czechia|France|Germany|Hong Kong|Hungary|Israel|Italy|Korea, Republic of|New Zealand|Poland|Russian Federation|Singapore|Slovakia|Spain|Sweden|Taiwan|Ukraine|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Czechia|Denmark|France|Germany|Hungary|Italy|Korea, Republic of|Netherlands|New Zealand|Poland|Russian Federation|Spain|Sweden|Taiwan|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Czechia|France|Israel|Italy|New Zealand|Poland|Russian Federation|Spain|Sweden|Turkey|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|France|Germany|Italy|Japan|Norway|Spain 1
United States|Australia|Austria|Belgium|Czechia|France|Italy|New Zealand|Poland|Russian Federation|Spain|Sweden|Taiwan|United Kingdom 1
United States|Australia|Austria|Belgium|France|Ireland|Italy|Poland|Spain|United Kingdom 1
United States|Australia|Austria|Canada|Denmark|France|Israel|Italy|Netherlands|Spain|Switzerland|United Kingdom 1
United States|Australia|Belgium|Canada|Croatia|Czechia|France|Greece|Hungary|Ireland|Italy|Poland|Portugal|Romania|Russian Federation|Spain|Turkey|United Kingdom 1
United States|Australia|Belgium|Canada|Denmark|France|Hungary|Italy|Netherlands|New Zealand|Norway|Poland|Romania|Russian Federation|Spain|Sweden|United Kingdom 1
United States|Australia|Belgium|Canada|Germany|New Zealand|Sweden|Turkey|United Kingdom 1
United States|Australia|Belgium|China|Czechia|France|Germany|Italy|Netherlands|New Zealand|Poland|Spain|Sweden|Turkey|United Kingdom 1
United States|Australia|Belgium|France|Germany|Italy|Netherlands|Puerto Rico|United Kingdom 1
United States|Australia|Belgium|Hungary|India|Poland|Singapore|Spain|Taiwan|Turkey 1
United States|Australia|Brazil|Canada 1
United States|Australia|Brazil|Canada|Denmark|Finland|France|Germany|Italy|Korea, Republic of|Netherlands|Norway|Russian Federation|Spain|Sweden|Taiwan|United Kingdom 1
United States|Australia|Brazil|Czech Republic|France|Israel|Italy|Poland|Puerto Rico|Russian Federation|Ukraine|United Kingdom 1
United States|Australia|Canada|France|Germany|Korea, Republic of|Spain|United Kingdom 1
United States|Australia|Canada|France|Germany|Poland|United Kingdom 1
United States|Australia|Canada|Italy|Puerto Rico|United Kingdom 1
United States|Australia|Canada|Netherlands|New Zealand|Puerto Rico|Switzerland 1
United States|Australia|Canada|New Zealand|Puerto Rico|Saudi Arabia 1
United States|Australia|Canada|Switzerland 1
United States|Australia|France|Germany|Israel|Korea, Republic of|Spain 1
United States|Australia|France|Germany|Italy|Japan|Korea, Republic of|Netherlands|Singapore|Spain 1
United States|Australia|France|Italy|Spain 1
United States|Australia|Germany|United Kingdom 1
United States|Australia|Israel|Poland|Ukraine 1
United States|Australia|Italy|New Zealand|Spain 1
United States|Australia|New Zealand 1
United States|Austria 1
United States|Austria|Belgium|Canada|Denmark|Finland|France|Germany|Greece|Ireland|Israel|Italy|Netherlands|Norway|Portugal|Puerto Rico|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
United States|Austria|Belgium|Czech Republic|France|Germany|Ireland|Italy|Netherlands|Sweden|United Kingdom 1
United States|Austria|Bulgaria|Canada|Croatia|France|Germany|Greece|Italy|Poland|Portugal|Romania|Russian Federation|Sweden|Ukraine 1
United States|Austria|Canada|France|Germany|Italy|Netherlands 1
United States|Austria|Germany|Italy|Poland|United Kingdom 1
United States|Austria|Germany|Italy|Spain 1
United States|Austria|Germany|Poland|Spain 1
United States|Belgium|Canada|Czechia|Denmark|France|Israel|Netherlands|Poland|Russian Federation|Spain|Sweden|Turkey|United Kingdom 1
United States|Belgium|Canada|Denmark|Finland|France|Germany|Italy|Netherlands|Norway|Spain|United Kingdom 1
United States|Belgium|Canada|France|Germany|Israel|Italy|Poland 1
United States|Belgium|Czech Republic|France|Serbia|United Kingdom 1
United States|Belgium|Czech Republic|Greece|Italy|Poland|Russian Federation|Spain 1
United States|Belgium|France|Germany|Israel|Italy|Netherlands|Spain|Sweden|United Kingdom 1
United States|Belgium|France|Italy|Netherlands|Spain 1
United States|Brazil|Bulgaria|Canada|Germany|Greece|India|Italy|Mexico|Netherlands|Poland|Romania|Russian Federation|Spain|Taiwan|Thailand|Ukraine|United Kingdom 1
United States|Brazil|France|Italy|Korea, Republic of|Netherlands|Russian Federation|United Kingdom 1
United States|Canada|France|Germany|Italy|Spain|Sweden|United Kingdom 1
United States|Canada|France|Germany|Netherlands 1
United States|Canada|Georgia|Moldova, Republic of|Poland|Spain|Ukraine 1
United States|Canada|Germany|Israel|United Kingdom 1
United States|Canada|Germany|Italy|Spain|Sweden|United Kingdom 1
United States|Canada|Israel|Puerto Rico 1
United States|Canada|Netherlands|Puerto Rico|Switzerland 1
United States|Canada|Puerto Rico|South Africa 1
United States|Canada|Puerto Rico|Switzerland 1
United States|Denmark 1
United States|Denmark|France|United Kingdom 1
United States|Denmark|Italy 1
United States|Egypt|India 1
United States|France 1
United States|France|Germany|Italy|Japan|Netherlands|United Kingdom 1
United States|France|Germany|Italy|Spain|United Kingdom 1
United States|France|Germany|Italy|Switzerland|United Kingdom 1
United States|France|Italy|Spain 1
United States|France|Japan|United Kingdom 1
United States|France|Spain|United Kingdom 1
United States|Germany|Israel 1
United States|Germany|Italy|Spain 1
United States|Hungary|Israel|Italy|Spain 1
United States|Israel 1
United States|Israel|Italy|Poland|Russian Federation|Spain|United Kingdom 1
United States|Italy|United Kingdom 1
United States|Japan 1
United States|Poland 1
United States|Puerto Rico 1
United States|Sweden 1
United States|Switzerland 1

Sites per Study

Site_count Study_Count
1 535
2 84
3 49
4 34
5 32
6 35
7 16
8 12
9 12
10 17
11 20
12 16
13 11
14 9
15 9
16 9
17 6
18 9
19 5
20 4
21 4
22 13
23 6
24 5
25 7
26 4
27 4
28 6
29 1
30 4
31 3
32 2
33 9
34 8
35 5
36 3
38 2
39 2
41 1
42 2
43 2
44 2
46 3
48 3
50 4
51 3
52 2
53 1
54 2
55 1
56 1
57 1
58 3
60 1
61 1
63 1
64 1
66 1
67 1
69 2
70 1
71 3
72 1
75 2
76 2
78 1
79 1
80 1
81 2
84 1
85 1
86 2
87 2
88 2
91 3
92 1
94 1
97 1
101 3
102 1
103 1
106 2
107 1
108 2
111 1
115 1
117 3
119 1
122 1
123 3
128 1
130 1
134 1
135 2
139 1
145 1
150 2
153 1
157 1
160 3
161 1
162 1
164 1
165 1
170 1
171 1
173 2
174 1
186 1
188 1
196 1
198 1
199 1
211 1
212 1
215 1
218 1
224 1
225 1
239 1
241 1
244 1
262 3
299 1
364 1
551 1
747 1
796 1
837 1
954 1

Phase

Phase Study_Count
Phase 2 464
Phase 1 271
Phase 1/Phase 2 162
Phase 3 131
N/A 61
Phase 4 31
Phase 2/Phase 3 16
Early Phase 1 10

Number of Arms

Number_of_Arms Count_of_Studies
1 650
2 235
3 60
4 32
5 14
6 7
7 8
8 5
9 2
10 6
11 1
12 1
17 1
NA 124

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 4.00 2.0000 2.00000 1.0000 2.00000 10.0000 40.000 9.0000
1st Qu. 6.25 30.7500 16.00000 30.0000 30.00000 37.5000 211.000 65.0000
Median 16.50 59.5000 28.00000 42.0000 50.00000 80.0000 400.000 100.0000
Mean 46.90 191.6207 41.93309 68.6478 70.02444 190.9375 851.969 277.4839
3rd Qu. 33.75 103.5000 48.00000 79.5000 86.00000 137.5000 780.000 347.5000
Max. 312.00 4000.0000 746.00000 942.0000 470.00000 1000.0000 9350.000 2600.0000

Trial Group Type

group_type Group_Count
Experimental 1460
Active Comparator 188
NA 124
No Intervention 42
Other 41
Placebo Comparator 22
Sham Comparator 1

Intervention Model

intervention_model Study_Count
Single Group Assignment 768
Parallel Assignment 278
NA 50
Sequential Assignment 29
Crossover Assignment 14
Factorial Assignment 7

Primary Purpose

primary_purpose Study_Count
Treatment 1075
Supportive Care 35
Prevention 17
Basic Science 9
Other 4
NA 4
Diagnostic 1
Health Services Research 1

Observational Studies

Studies by Country

Country Study_Count
United States 45
France 11
NA 9
Denmark 8
Italy 7
Korea, Republic of 5
Greece 4
Israel 4
Russian Federation 4
Canada 3
Spain 3
Argentina 2
India 2
Ireland|United Kingdom 2
Mexico 2
Sweden 2
United Kingdom 2
Austria|Germany|Italy 1
Austria|Germany|Switzerland 1
Belgium 1
Belgium|France|Portugal 1
China 1
Czech Republic|France|Germany|Italy|Poland|Russian Federation|Spain|United Kingdom 1
Czechia 1
Denmark|Finland|Iceland|Lithuania|Norway|Sweden 1
Denmark|Finland|Iceland|Norway|Sweden 1
Egypt 1
Finland 1
Germany 1
Guatemala 1
Hungary 1
Indonesia 1
Italy|Switzerland 1
Japan 1
Serbia 1
Switzerland 1
United States|Australia|Canada 1
United States|Australia|Canada|Ireland|New Zealand|Puerto Rico|Switzerland 1
United States|Australia|Canada|New Zealand 1
United States|Australia|Canada|New Zealand|Puerto Rico|Switzerland 1
United States|Australia|Canada|Puerto Rico|Switzerland 1
United States|Canada 1
United States|Czech Republic|France|Germany|Italy|Poland|Spain|United Kingdom 1
United States|Netherlands 1

Sites per Study

Site_count Study_Count
1 80
2 6
3 7
4 2
5 5
6 1
8 1
9 2
10 2
11 1
13 2
14 2
15 2
16 1
17 2
18 1
19 2
21 1
25 1
31 1
33 1
34 1
35 1
39 1
41 2
47 1
51 1
55 1
59 1
66 1
71 1
84 1
112 1
135 1
137 1
165 1
183 1
200 1
244 1

Enrollment Metrics

Measure Observational
Min 1.0000
1st Qu 60.0000
Median 153.0000
Mean 719.7234
3rd Qu 418.0000
Max 17463.0000

Observation Model

observational_model Study_Count
Cohort 81
Case-Only 26
Other 10
NA 8
Case-Control 7
Case Control 5
Family-Based 3
Case-Crossover 1
Defined Population, Natural History 1

Time Perspective

time_perspective Study_Count
Prospective 82
Retrospective 37
Cross-Sectional 9
Other 8
NA 4
Cross-Sectional, Retrospective 1
Longitudinal, Prospective 1

Registries

Studies by Country

Country Study_Count
United States 5
France 2
NA 2
China 1
Czechia 1
Germany 1
Indonesia 1
Italy 1
Sweden 1
Turkey 1

Sites per Study

Site_count Study_Count
1 10
2 3
11 1
51 1
192 1

Enrollment Metrics

Measure Registries
Min 24.000
1st Qu 199.500
Median 510.500
Mean 2177.125
3rd Qu 2448.750
Max 10000.000

Registry Model

observational_model Study_Count
Cohort 11
Other 4
Case-Only 1

Time Perspective

time_perspective Study_Count
Prospective 12
Cross-Sectional 2
Other 2

Follow-up

target_duration Study_Count
10 Years 5
2 Years 3
1 Year 2
1 Day 1
12 Months 1
15 Years 1
20 Years 1
3 Years 1
5 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT04456959 InO - A Retrospective Study of UK Patients With Leukaemia https://ClinicalTrials.gov/show/NCT04456959 Recruiting Pfizer 2020-12-31
NCT03627208 Optimal Methods of Disease Detection in Children and Young Adults With Acute Lymphoblastic Leukemia in the Pediatric Oncology Branch https://ClinicalTrials.gov/show/NCT03627208 Enrolling by invitation National Institutes of Health Clinical Center (CC) 2021-12-31
NCT03374137 Observational Study to Monitor Safety and Effectiveness of Obinutuzumab in Follicular Lymphoma or Previously Untreated Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT03374137 Recruiting Hoffmann-La Roche 2020-09-30
NCT03342144 Study of the Use of Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting https://ClinicalTrials.gov/show/NCT03342144 Recruiting AbbVie 2022-12-31
NCT03294980 Chronic Lymphoid Leukaemia Observatory in Finistere Area, France https://ClinicalTrials.gov/show/NCT03294980 Recruiting University Hospital, Brest 2025-11-30
NCT03289182 An Observational Study of MabThera Subcutaneous (SC) Safety in Participants With Non-Hodgkin’s Lymphoma (NHL) or Chronic Lymphocytic Leukemia (CLL) https://ClinicalTrials.gov/show/NCT03289182 Active, not recruiting Hoffmann-La Roche 2020-10-26
NCT03231579 Chronic Lymphocytic Leukemia Electronic Patient Reported Outcomes Study https://ClinicalTrials.gov/show/NCT03231579 Completed Carevive Systems, Inc. 2018-11-01
NCT03123887 Evaluate the Hematological Remission Rates and Survival Among Chinese Adult Patients With B-precursor ALL https://ClinicalTrials.gov/show/NCT03123887 Completed Harbin Hematology and Oncology Institute 2016-06-03
NCT03067584 Genetic Study of Familial Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT03067584 Completed St. Jude Children’s Research Hospital 2017-06-23
NCT03059251 Observational Study: Safety and Effectiveness of Obinutuzumab in Chronic Lymphocytic Leukemia in Argentina https://ClinicalTrials.gov/show/NCT03059251 Completed Hoffmann-La Roche 2019-03-30
NCT03000335 Evaluation of ProALL miRs in Blood Specimen for Prediction of ALL Relapse Risk https://ClinicalTrials.gov/show/NCT03000335 Recruiting Curewize Health Ltd. 2020-05-31
NCT02915224 A Study of Obinutuzumab Evaluating Efficacy, Safety and Cost of Disease Management in Participants With Chronic Lymphocytic Leukemia and Comorbidities https://ClinicalTrials.gov/show/NCT02915224 Active, not recruiting Hoffmann-La Roche 2020-04-30
NCT02888977 Tyrosine Kinase Inhibitors and Low Intensity Chemotherapy in Ph+ ALL https://ClinicalTrials.gov/show/NCT02888977 Recruiting Versailles Hospital 2020-12-31
NCT02842229 A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms https://ClinicalTrials.gov/show/NCT02842229 Completed Celgene 2017-02-02
NCT02827617 Identification of Biomarkers That Are Predictive of Early Ibrutinib Treatment Failure in High Risk TP53 Mutated Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT02827617 Recruiting Oncology Institute of Southern Switzerland 2021-02-28
NCT02767388 Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery https://ClinicalTrials.gov/show/NCT02767388 Completed University of Nebraska 2017-12-11
NCT02617004 Multicenter Trial Treatment of Philadelphia Chromosome Negative B-cell Acute Lymphoblastic Leukemia of Young Adults https://ClinicalTrials.gov/show/NCT02617004 Recruiting Assistance Publique - Hôpitaux de Paris 2020-12-31
NCT02582320 Clinical-biological Characteristics and Outcome of Chronic Lymphocytic Leukemia Under Ibrutinib-named Patient Program https://ClinicalTrials.gov/show/NCT02582320 Recruiting Gruppo Italiano Malattie EMatologiche dell’Adulto 2018-12-31
NCT00923442 Biology Studies of Hematologic Cancers https://ClinicalTrials.gov/show/NCT00923442 Enrolling by invitation National Institutes of Health Clinical Center (CC) NA
NCT00268528 Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission https://ClinicalTrials.gov/show/NCT00268528 Completed Children’s Oncology Group 2012-03-05
NCT00131014 Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies https://ClinicalTrials.gov/show/NCT00131014 Recruiting Dana-Farber Cancer Institute 2023-01-31
NCT02520895 Immunological Repertoire in Patients With Lymphoma and Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT02520895 Completed Hospices Civils de Lyon 2013-10-31
NCT02491398 Efficacy and Safety of Bendamustine Plus Rituximab in Chronic Lympocytic Leukemia https://ClinicalTrials.gov/show/NCT02491398 Active, not recruiting Gruppo Italiano Malattie EMatologiche dell’Adulto 2018-10-31
NCT02461316 Rituximab in Combination With Fludarabine and Cyclophosphamide in Patients With Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT02461316 Completed Hoffmann-La Roche 2011-12-31
NCT02434484 Symbenda Post-Marketing Surveillance (PMS) https://ClinicalTrials.gov/show/NCT02434484 Active, not recruiting Eisai Inc. 2020-04-30
NCT02414022 Economic Analysis of Alliance A041202 CLL Study https://ClinicalTrials.gov/show/NCT02414022 Active, not recruiting Canadian Cancer Trials Group 2019-04-05
NCT02381899 Observational Study in CLL Patients Receiving BR https://ClinicalTrials.gov/show/NCT02381899 Completed Czech CLL Study Group 2016-12-31
NCT02303522 Historical Data Analysis of Complete Remission in Children With R/R Acute Lymphoblastic Leukemia (ALL) https://ClinicalTrials.gov/show/NCT02303522 Completed Amgen 2015-01-22
NCT02272673 The Effects of Honey on Febrile Neutropenia in Children With Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT02272673 Completed Ain Shams University 2013-08-31
NCT02269592 Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome https://ClinicalTrials.gov/show/NCT02269592 Recruiting Dana-Farber Cancer Institute 2024-12-31
NCT02110394 Ribomustin in the First Line Therapy of Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT02110394 Completed Astellas Pharma Inc 2015-08-31
NCT02080884 An Observational Study Examining the Effect of Added MabThera Therapy in Patients With Untreated Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT02080884 Completed Hoffmann-La Roche 2016-12-19
NCT01295476 Biomarker Study in Bone Marrow Samples From Patients With T-Cell Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01295476 Completed Children’s Oncology Group 2013-05-31
NCT01284010 Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01284010 Completed Alliance for Clinical Trials in Oncology 2014-09-30
NCT03310190 Study to Describe the Management and the Use of Healthcare Resources in Patients With Chronic Lymphocytic Leukemia (CLL) Initiating Venetoclax in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT03310190 Recruiting AbbVie 2021-06-30
NCT02010931 Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia Patients https://ClinicalTrials.gov/show/NCT02010931 Completed Amgen 2014-03-31
NCT02003612 Historical Data Analysis of Hematological Remission and Survival in Adults With R/R Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT02003612 Completed Amgen 2014-01-31
NCT01896752 Renal and Hepatic Clearance Following High-Dose Methotrexate in Childhood ALL https://ClinicalTrials.gov/show/NCT01896752 Completed Rigshospitalet, Denmark 2013-01-31
NCT01886651 The Influence of Thiopurine Methyltransferase Activity on Toxicity After High-dose Methotrexate in Childhood Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01886651 Completed Rigshospitalet, Denmark 2012-02-29
NCT01678508 Pharmacogenetically Based Dosing of Thiopurines in Childhood Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01678508 Completed Rigshospitalet, Denmark 2011-07-31
NCT01625143 Studying Genes in Samples From Younger Patients With Relapsed Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01625143 Completed Children’s Oncology Group 2016-05-31
NCT01609023 A Study of Rituximab (MabThera) in Combination With Chemotherapy in Participants With CD20-Positive B-Cell Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT01609023 Completed Hoffmann-La Roche 2015-11-30
NCT01581528 Studying Samples From Patients With T-Cell Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01581528 Completed Children’s Oncology Group 2016-05-31
NCT01565447 Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma Gait Parameters Study https://ClinicalTrials.gov/show/NCT01565447 Active, not recruiting Oregon Health and Science University 2020-12-31
NCT01556386 Pharmacogenetic Analysis of Korean Pediatric Patients With Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01556386 Completed Seoul National University Hospital 2012-03-31
NCT01553162 Studying Dexamethasone and Prednisone Sensitivity in Samples From Younger Patients With High-Risk B-Cell Precursor Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01553162 Completed Children’s Oncology Group 2016-05-31
NCT01540812 Treatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTS https://ClinicalTrials.gov/show/NCT01540812 Completed PETHEMA Foundation 2019-11-20
NCT01540578 Studying Biomarkers as a Diagnostic Tool in Samples From Younger Patients With B-Cell Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01540578 Completed Children’s Oncology Group 2016-05-31
NCT01533168 Genetic Test To Identify Previously Undetectable Minimal Residual Disease in Cell Samples From Younger Patients With Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01533168 Completed Children’s Oncology Group 2016-05-31
NCT01505699 Biomarkers in Samples From Patients With B-Cell Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01505699 Completed Eastern Cooperative Oncology Group 2012-02-06
NCT01488162 An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT01488162 Completed Hoffmann-La Roche 2016-10-24
NCT01476462 Second Malignant Neoplasms After Childhood ALL Therapy https://ClinicalTrials.gov/show/NCT01476462 Completed Rigshospitalet, Denmark 2011-04-30
NCT01470924 Acute Lymphoblastic Leukemia Relapse in Sweden 2003-2007 https://ClinicalTrials.gov/show/NCT01470924 Completed Region Örebro County NA
NCT01460238 Lipoprotein Lipase Expression in Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT01460238 Completed Dartmouth-Hitchcock Medical Center 2018-05-31
NCT01453062 Phase IV Observational Study in Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT01453062 Completed GlaxoSmithKline 2012-11-30
NCT01439217 Endothelial Function, Arterial Stiffness and Components https://ClinicalTrials.gov/show/NCT01439217 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2013-02-28
NCT01397916 Indoleamine 2,3-dioxygenase (IDO) Activity in Patients With Chronic Lymphocytic Leukemia (CLL) https://ClinicalTrials.gov/show/NCT01397916 Completed Tampere University Hospital 2010-12-31
NCT01395615 An Observational Study on The Health Related Quality of Life in Patients With Chronic Lymphocytic Leukaemia https://ClinicalTrials.gov/show/NCT01395615 Completed Hoffmann-La Roche 2009-10-31
NCT01393249 PEG-Asparaginase Associated Pancreatitis, Hepatotoxicity and Hyperlipidemia in Children With ALL https://ClinicalTrials.gov/show/NCT01393249 Completed Rigshospitalet, Denmark 2013-12-31
NCT01380587 Utility of XCL1 as a Prognostic Marker in Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01380587 Completed Hospital Universitario Dr. Jose E. Gonzalez 2012-09-30
NCT04364451 Correlation of Polymorphisms of Lipoprotein Lipase (LpL) and Apolipoprotein E (Apo E) With Lipid Profile of Children With Acute Lymphoblastic Eukaemia During Therapy With L - Asparaginase. https://ClinicalTrials.gov/show/NCT04364451 Recruiting Aristotle University Of Thessaloniki 2022-08-31
NCT04322084 Continuous Ambulatory Monitoring to Predict Elevated Risk of Infection in Children With Lymphoblastic Leukemia Undergoing Induction Chemotherapy (CAMPER-ALL) https://ClinicalTrials.gov/show/NCT04322084 Recruiting St. Jude Children’s Research Hospital 2021-05-01
NCT04290000 Collection of Biological Samples From Patients Treated With CAR-T Cells for Hematological Malignancies https://ClinicalTrials.gov/show/NCT04290000 Recruiting University Hospital, Montpellier 2025-02-25
NCT04290923 Determination of Blood Tumor Cells https://ClinicalTrials.gov/show/NCT04290923 Recruiting University of Zurich 2020-09-30
NCT04271215 Overweight and Obesity as Prognostic Factors for Survival in Children With Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT04271215 Recruiting Coordinación de Investigación en Salud, Mexico 2020-12-31
NCT04198415 A Study of the Safety and Efficacy of Venetoclax in Japanese Participants With Relapsed and Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Leukemia) https://ClinicalTrials.gov/show/NCT04198415 Recruiting AbbVie 2022-03-31
NCT04187248 The Association Between Asparaginase Enzyme Activity Levels and Toxicities in Childhood Acute Lymphoblastic Leukaemia in NOPHOALL 2008 https://ClinicalTrials.gov/show/NCT04187248 Completed Aarhus University Hospital 2016-02-28
NCT04178317 A Study of the Safety and Efficacy of Venetoclax for Participants With Chronic Lymphocytic Leukemia (CLL) Used in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT04178317 Recruiting AbbVie 2026-03-25
NCT04159779 A Study of Clinical Outcomes in Relapse/Refractory Chronic Lymphocytic Leukemia (CLL) Patients Treated With Venetoclax in Greece https://ClinicalTrials.gov/show/NCT04159779 Recruiting AbbVie 2020-11-25
NCT04055558 Lymphoproliferative Disorders During the Treatment of Childhood Acute Lymphoblastic Leukemia/Lymphoma https://ClinicalTrials.gov/show/NCT04055558 Recruiting Rabin Medical Center 2019-12-18
NCT04028531 Understanding Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT04028531 Recruiting Dana-Farber Cancer Institute 2024-09-29
NCT04016636 A Study to Evaluate Impact of Ibrutinib on the Quality of Life (QOL) in Patients With Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT04016636 Recruiting Fundaleu 2021-08-31
NCT03974893 Dietary Intake, Sarcopenic Obesity, and Other Treatment-Related Outcomes in Indian Children With Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT03974893 Recruiting Columbia University 2021-11-30
NCT03985826 Primary Health Care Utilisation Among Survivors of Childhood Acute Lymphoblastic Leukaemia https://ClinicalTrials.gov/show/NCT03985826 Completed University of Aarhus 2019-11-30
NCT03971565 Evaluation of the Redox Profiles of Healthy and Pathological B Cells in Patients With Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT03971565 Recruiting Assistance Publique Hopitaux De Marseille 2021-03-18
NCT03911128 A Treatment Protocol for Participants 1-45 Years With Acute Lymphoblastic Leukaemia https://ClinicalTrials.gov/show/NCT03911128 Recruiting Karolinska University Hospital 2020-03-31
NCT03898128 ItaliaN Observational Study of Patients With Acute Lymphoblastic Leukemia Treated With Anti-CD22 Immunoconjugate https://ClinicalTrials.gov/show/NCT03898128 Recruiting Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori 2020-10-31
NCT03873857 A Study to Assess Effectiveness of Venclexta (Venetoclax) in Patients With Relapse or Refractory Chronic Lymphocytic Leukemia in Routine Clinical Practice in Russian Federation https://ClinicalTrials.gov/show/NCT03873857 Recruiting AbbVie 2022-12-03
NCT03847727 Bendamustine and Rituximab (BR) as Induction and Maintenance in Relapsed and Refractory Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT03847727 Active, not recruiting Pirogov Russian National Research Medical University 2019-12-03
NCT03803670 Clinical Significance of Occult Central Nervous System Disease In Adult Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT03803670 Completed University of Rome Tor Vergata 2019-01-01
NCT03751072 Efficacy and Toxicity of Blinatumomab in the French ATU for Adult BCP-ALL R/R, or With MRD+ (FRENCH-CYTO) https://ClinicalTrials.gov/show/NCT03751072 Recruiting Group for Research in Adult Acute Lymphoblastic Leukemia 2018-11-30
NCT03720561 A Study to Evaluate Ibrutinib Retention in Chronic Lymphocytic Leukemia Participants Treated in a Real World Setting https://ClinicalTrials.gov/show/NCT03720561 Active, not recruiting Janssen-Cilag S.p.A. 2021-10-31
NCT03678454 Iclusig® (Ponatinib) in Clinical Practice for the Treatment of Chronic Myeloid Leukemia or Ph+ Acute Lymphoblastic Leukemia in Belgium https://ClinicalTrials.gov/show/NCT03678454 Recruiting Incyte Corporation 2022-03-31
NCT03659669 A Study to Describe the Effectiveness and Safety of Venetoclax Treatment in Chronic Lymphocytic Leukemia (CLL) Patients in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT03659669 Recruiting AbbVie 2024-10-31
NCT03582098 Clinical Outcomes and Routine Management of Adults With Chronic Lymphocytic Leukaemia Treated With Idelalisib and Rituximab in the United Kingdom (UK) and Ireland https://ClinicalTrials.gov/show/NCT03582098 Completed Gilead Sciences 2019-03-26
NCT03581045 Postural Control Under Different Cognitive Loads in Adult Survivors of Acute Lymphoblastic Leukemia and Age-Matched Healthy Individuals https://ClinicalTrials.gov/show/NCT03581045 Active, not recruiting St. Jude Children’s Research Hospital 2020-06-30
NCT03568266 Pharmacogenomics of Asparaginase Induced Hepatotoxicity https://ClinicalTrials.gov/show/NCT03568266 Recruiting University of Southern California 2024-05-22
NCT03545659 Childhood Acute Lymphoblastic Leukaemia: Follow-Up https://ClinicalTrials.gov/show/NCT03545659 Recruiting University of Aarhus 2020-06-30
NCT03528941 The Incidence of Hepatitis B Reactivations in Patients Affected by Chronic Lymphocytic Leukemia With Ibrutinib https://ClinicalTrials.gov/show/NCT03528941 Recruiting Gruppo Italiano Malattie EMatologiche dell’Adulto 2020-08-31
NCT03471416 Nutritional Status in Children With ALL in Guatemala https://ClinicalTrials.gov/show/NCT03471416 Recruiting Columbia University 2021-01-31
NCT03476655 Clinical Outcomes of Chronic Lymphocytic Leukemia (CCL) and Mantle Cell Lymphoma (MCL) Participants Treated With Ibrutinib: A Medical Chart Review From India https://ClinicalTrials.gov/show/NCT03476655 Completed Johnson & Johnson Private Limited 2019-05-14
NCT03436524 A Prognostic Tool for Early Stage CLL https://ClinicalTrials.gov/show/NCT03436524 Recruiting Oncology Institute of Southern Switzerland 2020-02-28
NCT03425591 A Study of Ibrutinib in the Treatment of Chronic Lymphocytic Leukemia and Mantle-cell Lymphoma in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT03425591 Recruiting Janssen-Cilag Ltd. 2022-05-22
NCT03415035 Study Venetoclax Effectiveness and Real‐Life Treatment Management in Participants With Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT03415035 Recruiting AbbVie 2022-03-30
NCT01224093 An Observational Study on the Safety Profile of MabThera/Rituxan (Rituximab) in Combination With Chemotherapy in Patients With B Cell-lineage Chronic Lymphocytic Leukaemia (MABERYC) https://ClinicalTrials.gov/show/NCT01224093 Completed Hoffmann-La Roche 2014-02-28
NCT01199562 Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT01199562 Completed City of Hope Medical Center 2013-12-31
NCT01185886 Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01185886 Active, not recruiting European Organisation for Research and Treatment of Cancer - EORTC 2021-06-30
NCT01178086 A Study on Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL) https://ClinicalTrials.gov/show/NCT01178086 Completed Hoffmann-La Roche 2015-06-30
NCT01148927 Quality of Life Study for Adult Patients With Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01148927 Completed University Health Network, Toronto 2012-06-30
NCT01142427 Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01142427 Active, not recruiting Children’s Oncology Group 2015-05-01
NCT01144793 Biomarker To Evaluate Protein Profiles of Neutropenic Fever/Infection With Acute or Chronic Leukemias https://ClinicalTrials.gov/show/NCT01144793 Completed Stanford University 2008-06-30
NCT01119586 Biomarkers in DNA Samples From Patients With High-Risk Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01119586 Completed Children’s Oncology Group 2015-12-31
NCT01117142 A Study of the Kinetics of Lymphoid Cells in Patients With Monoclonal B-cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL), Mantle Cell Lymphoma (MCL) and Healthy Volunteers https://ClinicalTrials.gov/show/NCT01117142 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT01110863 Characterization of Proliferating Compartment in B-Cell Patients and in Healthy Aging Subjects https://ClinicalTrials.gov/show/NCT01110863 Completed Northwell Health 2016-02-12
NCT01110850 Direct Measurement of Leukemic Cell Turnover (Synthesis and Removal) in Patients With Chronic Lymphocytic Leukemia (CLL) Using Deuterated Water https://ClinicalTrials.gov/show/NCT01110850 Completed Northwell Health 2018-05-31
NCT01094392 Hemostasis During Asparaginase Treatment in Acute Lymphoblastic Leukemia(ALL) https://ClinicalTrials.gov/show/NCT01094392 Recruiting Aarhus University Hospital 2019-12-31
NCT01081015 Connectâ„¢ CLL: The Chronic Lymphocytic Leukemia Disease Registry https://ClinicalTrials.gov/show/NCT01081015 Completed Celgene 2017-12-31
NCT01078337 T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis https://ClinicalTrials.gov/show/NCT01078337 Completed Stanford University 2007-10-31
NCT01072240 An Observational Study on Infusion-related Adverse Events at Administration of MabThera (Rituximab) in Patients With Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT01072240 Completed Hoffmann-La Roche 2011-06-30
NCT01047020 Motor Proficiency And Physical Activity in Adult Survivors of Childhood Acute Lymphoblastic Leukemia (ALL) https://ClinicalTrials.gov/show/NCT01047020 Completed St. Jude Children’s Research Hospital 2013-04-30
NCT01030913 B-type Chronic Lymphocytic Leukemia (B-CLL) Subgroups: Maturation Stage and Gene Expression https://ClinicalTrials.gov/show/NCT01030913 Recruiting Northwell Health 2021-01-31
NCT01028430 B Cell Repertoires in Chronic Lymphocytic Leukemia and Aging https://ClinicalTrials.gov/show/NCT01028430 Recruiting Northwell Health 2021-01-31
NCT01014195 Risk of Psychopathology and Neurocognitive Impairment in Leukemia Survivors https://ClinicalTrials.gov/show/NCT01014195 Completed St. Jude Children’s Research Hospital 2014-10-31
NCT01016379 Studying DNA in Blood and Bone Marrow Samples From Young Patients With Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01016379 Completed Children’s Oncology Group 2016-05-31
NCT01005368 Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT01005368 Active, not recruiting Alliance for Clinical Trials in Oncology 2100-01-31
NCT00993135 Kidney Dysfunction in Children and Young Adults Who Have Received Methotrexate for Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT00993135 Completed Vanderbilt University Medical Center 2009-12-31
NCT00923507 Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL) https://ClinicalTrials.gov/show/NCT00923507 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00897325 Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma https://ClinicalTrials.gov/show/NCT00897325 Completed Children’s Oncology Group 2019-12-31
NCT00898755 Collecting and Storing Tissue From Young Patients With Cancer https://ClinicalTrials.gov/show/NCT00898755 Completed Children’s Oncology Group 2008-07-17
NCT00896766 Laboratory Study of Lymphoblasts in Young Patients With High-Risk Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT00896766 Completed Children’s Oncology Group 2016-05-31
NCT00898404 Response or Resistance to Chemotherapy in Young Patients With Acute Lymphoblastic Leukemia Treated With Methotrexate https://ClinicalTrials.gov/show/NCT00898404 Completed Children’s Oncology Group 2016-05-31
NCT03860376 Ex Vivo Drug Sensitivity Testing and Mutation Profiling https://ClinicalTrials.gov/show/NCT03860376 Recruiting Florida International University 2022-12-15
NCT03647215 CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey https://ClinicalTrials.gov/show/NCT03647215 Recruiting Incyte Corporation 2020-06-30
NCT03279900 Hematotoxicity in Acute Lymphoblastic Leukemia Children in Maintenance Phase Therapy https://ClinicalTrials.gov/show/NCT03279900 Completed Indonesia University 2018-05-16
NCT03633045 Observational Study of Ibrutinib Use in CLL https://ClinicalTrials.gov/show/NCT03633045 Recruiting Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health 2021-09-30
NCT00801346 Metabolic Syndrome in Young Patients With Acute Lymphoblastic Leukemia in Remission https://ClinicalTrials.gov/show/NCT00801346 Completed Vanderbilt University Medical Center 2016-04-30
NCT04437420 Preclinical Project on the Traitment of Acute Lymphoblastique Leukemia With NVP-BEP800, an Inhibitor of the Heat Shock Protein HSP90 https://ClinicalTrials.gov/show/NCT04437420 Recruiting Centre Hospitalier Universitaire Dijon 2021-09-30
NCT02783651 An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US https://ClinicalTrials.gov/show/NCT02783651 Completed Amgen 2020-03-31
NCT00664131 Neurologic Morbidity and Disability in Acute Lymphoblastic Leukemia Survivors https://ClinicalTrials.gov/show/NCT00664131 Completed St. Jude Children’s Research Hospital 2008-10-31
NCT00626496 Family Study of Lymphoproliferative Disorders https://ClinicalTrials.gov/show/NCT00626496 Recruiting Mayo Clinic 2025-12-31
NCT00552825 Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old Children https://ClinicalTrials.gov/show/NCT00552825 Completed Sheba Medical Center NA
NCT00505141 Urban Environmental Exposures and Childhood Cancer https://ClinicalTrials.gov/show/NCT00505141 Completed Georgetown University NA
NCT00503256 Genetic Study of Chronic Lymphocytic Leukemia Families https://ClinicalTrials.gov/show/NCT00503256 Active, not recruiting M.D. Anderson Cancer Center 2019-09-30
NCT00482352 Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT00482352 Completed Children’s Oncology Group 2012-04-30
NCT00481858 Kinetic Biomarker for Chronic Lymphocytic Leukemia Prognosis https://ClinicalTrials.gov/show/NCT00481858 Completed KineMed 2010-07-31
NCT00437060 Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT00437060 Completed Children’s Oncology Group 2015-09-30
NCT00344825 Vitalis Study - Observational Study on the Quality of Life in Patients Under Treatment for B-Chronic Lymphocytic Leukemia (B-CLL) https://ClinicalTrials.gov/show/NCT00344825 Completed Sanofi 2006-11-30
NCT00339664 Analyses of Human Samples Collected in Clinical Trials https://ClinicalTrials.gov/show/NCT00339664 Completed National Institutes of Health Clinical Center (CC) 2020-03-17
NCT00330538 Osteoporosis in Children With ALL https://ClinicalTrials.gov/show/NCT00330538 Completed Children’s Mercy Hospital Kansas City NA
NCT00085176 Neurobehavioral Complications in Children Who Were Previously Treated With Steroids and Intrathecal Therapy for Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT00085176 Completed Children’s Oncology Group 2009-09-30
NCT00048958 Cytogenetic Studies in Acute Leukemia and Multiple Myeloma https://ClinicalTrials.gov/show/NCT00048958 Active, not recruiting Alliance for Clinical Trials in Oncology 2100-01-31
NCT00003861 Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia https://ClinicalTrials.gov/show/NCT00003861 Active, not recruiting Alliance for Clinical Trials in Oncology 2100-01-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT04342117 Observational Trial of Real-World Treatment Utilization and Effectiveness of PI3K-inhibitors in CLL/SLL and FL https://ClinicalTrials.gov/show/NCT04342117 Recruiting Verastem, Inc. 2023-04-30
NCT03821727 SCT in Ph Positive Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT03821727 Completed University Hospital, Udine, Italy 2017-12-31
NCT03255668 Hematotoxicity in Maintenance Therapy of Children With Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT03255668 Completed Indonesia University 2018-10-15
NCT03197259 Chronic Lymphocytic Leukemia Registry Study - Multicenter Prospective National Study https://ClinicalTrials.gov/show/NCT03197259 Recruiting Izmir Hematologic Diseases and Cancer Research Help Association 2020-01-01
NCT02872987 GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial https://ClinicalTrials.gov/show/NCT02872987 Recruiting Goethe University 2025-12-31
NCT02869529 Institut Paoli Calmettes Chronic Lymphatic Leukemia Database https://ClinicalTrials.gov/show/NCT02869529 Recruiting Institut Paoli-Calmettes 2030-01-31
NCT02582879 informCLLâ„¢: A Disease Registry for Patients With Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT02582879 Active, not recruiting Pharmacyclics LLC. 2021-10-31
NCT02553304 Molecular Features Underlying Racial Differences in Survival of Taiwanese Chronic Lymphocytic Leukemia Patients https://ClinicalTrials.gov/show/NCT02553304 Active, not recruiting National Health Research Institutes, Taiwan 2019-01-25
NCT02298816 B-Cell Hematologic Malignancy Vaccination Registry https://ClinicalTrials.gov/show/NCT02298816 Enrolling by invitation Aurora Health Care 2024-12-31
NCT01950286 Hyper-CVAD Treatment of Adult T-cell Acute Lymphoblastic Leukemia in Sweden. https://ClinicalTrials.gov/show/NCT01950286 Completed Region Örebro County 2013-02-28
NCT01890486 The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen https://ClinicalTrials.gov/show/NCT01890486 Recruiting Wake Forest University Health Sciences 2023-05-31
NCT04094051 Observational Study of CLL/SLL Treatment and Ibrutinib Treatment of CLL/SLL in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT04094051 Recruiting The First Affiliated Hospital with Nanjing Medical University 2020-12-31
NCT03881592 Real-World Data Study Focused on Chronic Lymphocytic Leukemia (CLL) Patient Treatment Options and Their Effectiveness https://ClinicalTrials.gov/show/NCT03881592 Recruiting Brno University Hospital 2019-06-30
NCT03760237 Cardiovascular Function in Acute Leukemia https://ClinicalTrials.gov/show/NCT03760237 Enrolling by invitation Abramson Cancer Center of the University of Pennsylvania 2021-12-31
NCT03502876 Tolerance and Resistance to Ibrutinib in Patients With Chronic Lymphocytic Leukemia (CLL https://ClinicalTrials.gov/show/NCT03502876 Completed French Innovative Leukemia Organisation 2018-12-31
NCT00889798 Tumor Registry of Lymphatic Neoplasia https://ClinicalTrials.gov/show/NCT00889798 Completed iOMEDICO AG 2019-08-31